Peter Barrett

Peter Barrett

Chairman at SYNLOGIC, INC.

Net worth: 2 M $ as of 2024-02-28

71 year
Health Technology
Commercial Services
Health Services

Profile

He is also an Executive Fellow at Harvard Business School, where he is the faculty chair of the key advisory board of the Blavatnik Fellowship Program.
Peter is currently chairman of Synlogic (NASDAQ:SYBX), and also serves on the board Obsidian Therapeutics.
He previously served on the boards of past Atlas companies Cadent Therapeutics (acquired by Novartis), Larimar Therapeutics (NASDAQ:LRMR), Vitae Pharmaceuticals (NASDAQ:VTAE; acquired by Allergan), Stromedix (acquired by Biogen), Novamed (acquired by Sciclone), Alnylam (NASDAQ:ALNY), Harbour Antibodies (acquired by Harbour Biomed), Momenta (NASDAQ:MNTA), Sirion Therapeutics (acquired by Alcon and Bausch & Lomb), Infacare (acquired by Mallinckrodt), Archemix (acquired by Baxter) and a number of other ventures.
Prior to joining Atlas Peter was co-founder, executive vice president, and chief business officer of Celera Genomics, which announced the first successful sequencing of the human genome in 2001.
While at Celera, Peter led strategic alliances, acquisitions, and business strategy and helped launch it as a public company in 1999.
Prior to founding Celera, Peter held senior management positions at Applera, most recently serving as vice president of corporate planning and business development.
During his tenure, he ran several businesses and expanded the life science business through a series of licensing agreements, partnerships, and acquisitions.
Peter also serves on the board of Perkin Elmer (NYSE:PKI).
Peter received a BS in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell), and a PhD in analytical chemistry from Northeastern University.
He also completed Harvard Business School’s Management Development Program.
Outside the office, Peter enjoys skiing, competitive sailing, and the theater.
Peter and his wife Mary live in Boston.
They have three children, three granddaughters, and two grandsons.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-14 21,406 ( 0.02% ) 2 M $ 2024-02-28
2023-03-29 883 ( 0.00% ) 10 155 $ 2024-02-28
2024-01-01 0 ( -.--% ) - $ 2024-02-28

Peter Barrett active positions

CompaniesPositionStart
REVVITY, INC. Director/Board Member 2012-02-06
SYNLOGIC, INC. Chairman 2017-08-27
Harvard Business School Corporate Officer/Principal -
Director/Board Member 2022-01-18
Director/Board Member -
Director/Board Member 2019-12-16
Corporate Officer/Principal -
Chairman -
President -
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Peter Barrett

Former positions of Peter Barrett

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Peter Barrett's experience

Training of Peter Barrett

Northeastern University Doctorate Degree
University of Massachusetts Lowell Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Barrett's experience

Connections

100 +

1st degree connections

38

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
REVVITY, INC.

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

SYNLOGIC, INC.

Health Technology

LARIMAR THERAPEUTICS, INC.

Health Technology

Private companies31

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

PE Corp. (New York)

Health Technology

Commercial Services

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Analytical Life Science & Diagnostics Association

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Peter Barrett